Pay in 4 interest-free payments of $6.53 Learn more
Ships within 48 hours · Estimated delivery Sep 5 - Sep 10
PMID: 39937469
Image Credit: Love Employee / Shutterstock In a recent study published in the journal BMJ Medicine , researchers conducted a target trial emulation to assess associations between different scenarios of glucagon-like peptide-1 receptor agonist (GLP-1RA) treatment and the risk of major adverse cardiovascular events (MACE)
Last reviewed: July 2026
The Medicare GLP-1 Bridge launched July 1, 2026 , giving eligible Part D beneficiaries all forms of Wegovy for $50/month
US$ 20.24
US$ 20.64
US$ 23.01
US$ 27.73
US$ 22.90
US$ 24.60
US$ 26.73
US$ 20.58
US$ 24.09
US$ 28.08
